| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,023.6 | 956.0 |
| Profit before tax | 32.2 | 5.7 |
| Net income | 13.0 | 0.4 |
| EPS (diluted, $ a share) | $0.26 | $0.01 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +3372.4% |
|---|---|
| Revenue, year on year | +7.1% |
| Operating margin | 3.9% |
10-Q filed with the SEC, NASDAQ: ASTH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Astrana Health, Inc.: key numbers
- Share price
- $31.99Close, Nov 17
- Market cap
- $1.79B
- Shares outstanding
- 55.8MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Services-Management Consulting ServicesSIC 8742
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Astrana Health, Inc.
All →Astrana Health Financial Results
Astrana Health reported record third-quarter 2026 revenue of $1.02 billion, a 7% increase year-over-year, and record adjusted EBITDA of $77.2 million. Net income attributable to the company rose significantly to $13.0 million, or $0.26 per diluted share, driven by the execution of its AI-native healthcare operating platform.
- Term
- Q3 2026
“Our third quarter results demonstrate the growing impact of Astrana’s physician-centric, AI-native healthcare operating platform and our team’s continued focus on execution. We delivered record revenue, record adjusted EBITDA, and double-digit organic earnings growth while continuing to invest in the next phase of our growth.”
Brandon Sim, President and Chief Executive Officer
“By combining proprietary technology, aligned physician partnerships, and integrated care delivery, we’re building a scalable, repeatable model to improve patient outcomes and manage the total cost of care – a value proposition that extends across payer and reimbursement models and positions us to create sustainable long-term value for patients, physician partners, and shareholders.”
Brandon Sim, President and Chief Executive Officer
Astrana Health Investor Presentation
Astrana Health, Inc. has updated its corporate investor presentation for use in upcoming conferences and meetings. The presentation includes strategic highlights and forward-looking information regarding the company's business operations and financial objectives.
Astrana Health Cybersecurity Incident
Astrana Health disclosed a material cybersecurity incident involving social engineering and unauthorized access to its systems by threat actors impersonating company personnel. The company determined the incident is material as of September 22, 2026, due to the potential compromise of sensitive patient, employee, and provider data. Remedial actions including credential resets and system restorations have been implemented while a forensic investigation remains ongoing.
Astrana Health Investor Presentation
Astrana Health, Inc. filed an updated corporate investor presentation for September 2026 to be used in upcoming conferences and meetings. The presentation covers the company's business strategy, expansion plans, and financial targets, including its use of artificial intelligence capabilities.